Patient and Public Involvement (PPI) is a growing part of clinical research, and as such the National Institute for Health Research have released a pilot training resource surrounding PPI – free, and available via the NIHR Learn website (select the NIHR Endorsed Learning link).
PPI is defined as ‘research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them’, and there are clear benefits to incorporating this into your own research. The module will take you through the importance, theory and practice of PPI.
In applying for NIHR grants and funding, this is a core requirement. Likewise evidence of this activity having taken place, will be requested.
On the above website, there are further training modules available surrounding various key areas of clinical research.
If you wish to book onto any of the face-to-face Good Clinical Practice courses, please get in touch with Research Ethics.
NIHR resources – Patient and Public Involvement and Social Media Toolkit
Supporting patient and public involvement in research
Good public involvement in research – the perspective of a patient advocate
Free Patient and Public Involvement training for Parkinson’s researchers










The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease